Banco Santander’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.51M | Buy |
21,600
+4,850
| +29% | +$339K | 0.01% | 299 |
|
|
2025
Q1 | $1.23M | Buy |
16,750
+460
| +3% | +$33.8K | 0.01% | 299 |
|
|
2024
Q4 | $1.07M | Buy |
16,290
+920
| +6% | +$60.3K | 0.01% | 276 |
|
|
2024
Q3 | $1.2M | Sell |
15,370
-2,200
| -13% | -$171K | 0.01% | 271 |
|
|
2024
Q2 | $1.37M | Buy |
17,570
+4,770
| +37% | +$372K | 0.02% | 248 |
|
|
2024
Q1 | $867K | Sell |
12,800
-11,170
| -47% | -$757K | 0.01% | 287 |
|
|
2023
Q4 | $1.61M | Sell |
23,970
-10,750
| -31% | -$724K | 0.02% | 245 |
|
|
2023
Q3 | $2.35M | Sell |
34,720
-18,856
| -35% | -$1.28M | 0.03% | 225 |
|
|
2023
Q2 | $3.83M | Buy |
53,576
+12,996
| +32% | +$930K | 0.05% | 181 |
|
|
2023
Q1 | $2.82M | Sell |
40,580
-390
| -1% | -$27.1K | 0.04% | 161 |
|
|
2022
Q4 | $2.78M | Buy |
40,970
+440
| +1% | +$29.8K | 0.04% | 157 |
|
|
2022
Q3 | $2.22M | Sell |
40,530
-14,900
| -27% | -$817K | 0.03% | 180 |
|
|
2022
Q2 | $3.66M | Buy |
55,430
+7,480
| +16% | +$494K | 0.05% | 170 |
|
|
2022
Q1 | $3.18M | Buy |
47,950
+19,990
| +71% | +$1.33M | 0.03% | 199 |
|
|
2021
Q4 | $1.63M | Buy |
27,960
+6,230
| +29% | +$363K | 0.01% | 258 |
|
|
2021
Q3 | $1.31M | Buy |
21,730
+13,750
| +172% | +$826K | 0.01% | 264 |
|
|
2021
Q2 | $478K | Sell |
7,980
-1,430
| -15% | -$85.7K | ﹤0.01% | 326 |
|
|
2021
Q1 | $468K | Sell |
9,410
-240
| -2% | -$11.9K | ﹤0.01% | 323 |
|
|
2020
Q4 | $482K | Buy |
+9,650
| New | +$482K | ﹤0.01% | 310 |
|
|
2019
Q1 | – | Sell |
-29,490
| Closed | -$1.12M | – | 359 |
|
|
2018
Q4 | $1.12M | Sell |
29,490
-12,040
| -29% | -$457K | 0.01% | 231 |
|
|
2018
Q3 | $1.64M | Sell |
41,530
-4,420
| -10% | -$175K | 0.02% | 212 |
|
|
2018
Q2 | $1.61M | Buy |
+45,950
| New | +$1.61M | 0.02% | 206 |
|